Brain-derived neurotrophic factor from microglia: A molecular substrate for neuropathic pain

Neuron Glia Biology

Volumn 7, Issue 1, 2012, Pages 99-108

  Trang, Tuan ^a   Beggs, Simon ^a   Salter, Michael W ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

brain derived neurotrophic factor; chronic pain; Microglia; nerve injury; neuropathic pain; purinoceptors

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM ION; MITOGEN ACTIVATED PROTEIN KINASE P38; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y12 RECEPTOR;

CELL INTERACTION; CELL TYPE; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; HUMAN; MICROGLIA; NERVE CELL; NEUROMODULATION; NEUROPATHIC PAIN; NEUROPATHOLOGY; NOCICEPTION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM; CYTOKINES; HUMANS; MICROGLIA; NEURALGIA; RECEPTORS, PURINERGIC P2X;

EID: 84864680511     PISSN: 1740925X     EISSN: 17410533     Source Type: Journal    
DOI: 10.1017/S1740925X12000087     Document Type: Review

References (119)

1. Balkowiec A. and Katz D.M. (2002) Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. Journal of Neuroscience 22, 10399-10407.
2. Beggs S. and Salter M.W. (2010) Microglia-neuronal signalling in neuro-pathic pain hypersensitivity 2.0. Current Opinion in Neurobiology 20, 474-480.
3. Bernier L.P., Boue-Grabot E. and Seguela P. (2010) Functional modu-lation of P2X4 receptor-channels by UDP-activated P2Y6 receptors.
4. Bernier L.P., Ase A.R., Chevallier S., Blais D., Zhao Q., Boue-Grabot E. et al. (2008) Phosphoinositides regulate P2X4 ATP-gated channels through direct interactions. Journal of Neuroscience 28, 12938-12945.
5. Biber K., Tsuda M., Tozaki-Saitoh H., Tsukamoto K., Toyomitsu E., Masuda T. et al. (2011) Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. EMBO Journal.
6. Biggs J.E., Lu V.B., Stebbing M.J., Balasubramanyan S. and Smith P.A. (2010) Is BDNF sufficient for information transfer between microglia and dorsal horn neurons during the onset of central sensitization? Molecular Pain 6, 44.
7. Blanquet P.R. (2000) Identification of two persistently activated neurotrophin-regulated pathways in rat hippocampus. Neuroscience 95, 705-719.
8. Bobanovic L.K., Royle S.J. and Murrell-Lagnado R.D. (2002) P2X recep tor trafficking in neurons is subunit specific. Journal of Neuroscience 22, 4814-4824.
9. Boucsein C., Zacharias R., Farber K., Pavlovic S., Hanisch U.K. and Kettenmann H. (2003) Purinergic receptors on microglial cells: func-tional expression in acute brain slices and modulation of microglial activation in vitro. European Journal of Neuroscience 17, 2267-2276.
10. Brone B., Moechars D., Marrannes R., Mercken M. and Meert T. (2007) P2X currents in peritoneal macrophages of wild type and P2X4 mice. Immunology Letters 113, 83-89.
11. Broom D.C., Matson D.J., Bradshaw E., Buck M.E., Meade R., Coombs S. et al. (2008) Characterization of N-(adamantan-1-ylmethyl)-5-(3R-amino-pyrrolidin- 1-yl)methyl-2-chloro-ben zamide, a P2X7 antagonist in animal models of pain and inflammation. Journal ofPharmacology and Experimental Therapeutics 327, 620-633.
12. Buldyrev I., Tanner N.M., Hsieh H.Y., Dodd E.G., Nguyen L.T. and Balkowiec A. (2006) Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons. Journal of Neurochemistry 99, 1338-1350.
13. Burnstock G. (2006a) Pathophysiology and therapeutic potential ofpur-inergic signaling. Pharmacology Review 58, 58-86.
14. Burnstock G. (2006b) Purinergic P2 receptors as targets for novel analge-sics. Pharmacology and Therapeutics 110, 433-454.
15. Bushong E.A., Martone M.E., Jones Y.Z. and Ellisman M.H. (2002) Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. Journal of Neuroscience 22, 183-192.
16. Calvo M. and Bennett D.L. (2011) The mechanisms of microgliosis and pain following peripheral nerve injury. Experimental Neurology
17. Calvo M., Zhu N., Grist J., Ma Z., Loeb J.A. and Bennett D.L. (2011) Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. Glia 59, 554-568.
18. Chen W.G., Chang Q., Lin Y., Meissner A., West A.E., Griffith E.C. et al. (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation ofMeCP2. Science 302, 885-889.
19. Chessell I.P., Hatcher J.P., Bountra C., Michel A.D., Hughes J.P., Green P. et al. (2005) Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114, 386-396.
20. Clark A.K., Wodarski R., Guida F., Sasso O. and Malcangio M. (2010) Cathepsin S release from primary cultured microglia is regulated by the P2X7 receptor. Glia 58, 1710-1726.
21. Clark A.K., Yip P.K., Grist J., Gentry C., Staniland A.A., Marchand F. et al. (2007) Inhibition ofspinal microglial cathepsin S for the reversal ofneuropathic pain. Proceedings of the National Academy ofSciences of the U.S.A. 104, 10655-10660.
22. Collo G., Neidhart S., Kawashima E., Kosco-Vilbois M., North R.A. and Buell G. (1997) Tissue distribution of the P2X7 receptor. Neuropharmacology 36, 1277-1283.
23. Costigan M., Scholz J. and Woolf C.J. (2009) Neuropathic pain: a mala-daptive response of the nervous system to damage. Annual Review of Neuroscience 32, 1-32.
24. Coull J.A., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K. et al. (2005) BDNF from microglia causes the shift in neuronal anion gradi-ent underlying neuropathic pain. Nature 438, 1017-1021.
25. Coull J.A., Boudreau D., Bachand K., Prescott S.A., Nault F., Sik A. et al. (2003) Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism ofneuropathic pain. Nature 424, 938-942.
26. Coyle D.E. (1998) Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia 23, 75-83.
27. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S. et al. (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nature Neuroscience 8, 752-758.
28. de Jong E.K., Dijkstra I.M., Hensens M., Brouwer N., van A.M., Liem R.S. et al. (2005) Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. Journal of Neuroscience 25, 7548-7557.
29. De Koninck Y. (2007) Altered chloride homeostasis in neurological dis-orders: a new target. Current Opinion in Pharmacology 7, 93-99.
30. Dehez S., Daulhac L., Kowalski-Chauvel A., Fourmy D., Pradayrol L. and Seva C. (2001) Gastrin-induced DNA synthesis requires p38-MAPK activation via PKC/Ca(2+) and Src-dependent mechan-isms. FEBS Letters 496, 25-30.
31. Dell'Antonio G., Quattrini A., Cin E.D., Fulgenzi A. and Ferrero M.E. (2002) Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor, oxidized ATP. Arthritis and Rheumatology 46, 3378-3385.
32. Di V.F. (2006) Purinergic signalling between axons and microglia. Novartis Foundation Symposia 276, 253-258.
33. Donnelly-Roberts D.L. and Jarvis M.F. (2007) Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. British Journal ofPharmacology 151, 571-579.
34. Donnelly-Roberts D., McGaraughty S., Shieh C.C., Honore P. and Jarvis M.F. (2008) Painful purinergic receptors. Journal of Pharmacology and Experimental Therapeutics 324, 409-415.
35. Echeverry S., Shi X.Q. and Zhang J. (2008) Characterization ofcell pro-liferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. Pain 135, 37-47.
36. Farber K. and Kettenmann H. (2005) Physiology of microglial cells. Brain Research, Brain Research Reviews 48, 133-143.
37. Ferrari D., Villalba M., Chiozzi P., Falzoni S., Ricciardi-Castagnoli P. and Di V.F. (1996) Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. Journal ofImmunology 156, 1531-1539.
38. Fountain S.J. and North R.A. (2006) A C-terminal lysine that controls human P2X4 receptor desensitization. Journal of Biological Chemistry 281, 15044-15049.
39. Fujii K., Young M.T. and Harris K.D. (2011) Exploiting powder X-ray diffraction for direct structure determination in structural biology: the P2X4 receptor trafficking motif YEQGL. Journal of Structural Biology 174, 461-467.
40. Ghosh A., Carnahan J. and Greenberg M.E. (1994) Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263, 1618-1623.
41. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S. et al. (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845.
42. Grace P.M., Rolan P.E. and Hutchinson M.R. (2011) Peripheral immune contributions to the maintenance of central glial activation underlying neuropathic pain. Brain, Behavior, and Immunity 25, 1322-1332.
43. Graeber M.B. (2010) Changing face of microglia. Science 330, 783-788.
44. Gwak Y.S. and Hulsebosch C.E. (2009) Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neu-ropathic pain after spinal injury in rat. Neuroscience 161, 895-903.
45. Gwak Y.S. and Hulsebosch C.E. (2010) 'Gliopathy' maintains persistent hyperexcitability ofspinal dorsal horn neurons after spinal cord injury: substrate ofcentral neuropathic pain. In Costa A. and Villalba E. (eds) Horizons in Neuroscience Research, Volume 1. Hauppauge, NY: Nova Science Publishers Inc., pp. 195-224.
46. Hanisch U.K. and Kettenmann H. (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nature Neuroscience 10, 1387-1394.
47. Hepp R., Perraut M., Chasserot-Golaz S., Galli T., Aunis D., Langley K. et al. (1999) Cultured glial cells express the SNAP-25 analogue SNAP-23. Glia 27, 181-187.
48. Honore P., Donnelly-Roberts D., Namovic M.T., Hsieh G., Zhu C.Z., Mikusa J.P. et al. (2006) A-740003 N-(1-{(cyanoimino)(5-quinolinylamino) methylamino}-2, 2-dimethylpropyl)-2-(3, 4-dimethoxyphenyl)acetamide, a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. Journal of Pharmacology and Experimental Therapeutics 319, 1376-1385.
49. Honore P., Donnelly-Roberts D., Namovic M., Zhong C., Wade C., Chandran P. et al. (2009) The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice. Behavioral Brain Research 204, 77-81.
50. Inoue K. and Tsuda M. (2006) The role of microglia and ATP receptors in a mechanism ofneuropathic pain. Nippon Yakurigaku Zasshi 127, 14-17.
51. IOM (Institute of Medicine) (2011) Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, andResearch. Washington, DC: The National Academies Press.
52. Jarvis M.F. (2010) The neural-glial purinergic receptor ensemble in chronic pain states. Trends in Neurosciences 33, 48-57.
53. Ji R.R. and Woolf C.J. (2001) Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and mainten-ance ofpathological pain. Neurobiology of Disease 8, 1-10.
54. Jin S.X., Zhuang Z.Y., Woolf C.J. and Ji R.R. (2003) p38 mitogen activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contrib-utes to the generation of neuropathic pain. Journal of Neuroscience 23, 4017-4022.
55. Kawate T., Michel J.C., Birdsong W.T. and Gouaux E. (2009) Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 460, 592-598.
56. Keller A.F., Beggs S., Salter M.W. and De Koninck Y. (2007) Transformation of the output of spinal lamina I neurons after nerve injury and microglia stimulation underlying neuropathic pain. Molecular Pain 3, 27.
57. Kettenmann H., Hanisch U.K., Noda M. and Verkhratsky A. (2011) Physiology of microglia. Physiology Review 91, 461-553.
58. Kobayashi K., Yamanaka H., Fukuoka T., Dai Y., Obata K. and Noguchi K. (2008) P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. Journal of Neuroscience 28, 2892-2902.
59. Kolarow R., Brigadski T. and Lessmann V. (2007) Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. Journal of Neurosciences 27, 10350-10364.
60. Kreutzberg G.W. (1996) Microglia: a sensor for pathological events in the CNS. Trends in Neuroscience 19, 312-318.
61. Latremoliere A. and Woolf C.J. (2009) Central sensitization: a generator of pain hypersensitivity by central neural plasticity. Journal of Pain 10, 895-926.
62. Lauterborn J.C., Rivera S., Stinis C.T., Hayes V.Y., Isackson P.J. and Gall C.M. (1996) Differential effects of protein synthesis inhibition on the activity-dependent expression of BDNF transcripts: evidence for immediate-early gene responses from specific promoters. Journal of Neuroscience 16, 7428-7436.
63. Lawson L.J., Perry V.H., Dri P. and Gordon S. (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151-170.
64. Lever I., Cunningham J., Grist J., Yip P.K. and Malcangio M. (2003) Release of BDNF and GABA in the dorsal horn of neuropathic rats. European Journal of Neuroscience 18, 1169-1174.
65. Lipsky R.H., Xu K., Zhu D., Kelly C., Terhakopian A., Novelli A. et al. (2001) Nuclear factor kappaB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotection. Journal of Neurochemistry 78, 254-264.
66. Liu L., Tornqvist E., Mattsson P., Eriksson N.P., Persson J.K., Morgan B.P. et al. (1995) Complement and clusterin in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat Neuroscience 68, 167-179.
67. Lu V.B., Ballanyi K., Colmers W.F. and Smith P.A. (2007) Neuron type-specific effects of brain-derived neurotrophic factor in rat superficial dorsal horn and their relevance to 'central sensitization'. Journal of Physiology 584, 543-563.
68. Maeda M., Tsuda M., Tozaki-Saitoh H., Inoue K. and Kiyama H. (2010) Nerve injury-activated microglia engulfmyelinated axons in a P2Y12 signaling-dependent manner in the dorsal horn. Glia 58, 1838-1846.
69. Marini A.M., Jiang X., Wu X., Tian F., Zhu D., Okagaki P. et al. (2004) Role ofbrain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: from genes to phenotype. Restorative Neurology and Neuroscience 22, 121-130.
70. McGaraughty S., Chu K.L., Namovic M.T., Donnelly-Roberts D.L., Harris R.R., Zhang X.F. et al. (2007) P2X7-related modulation of pathological nociception in rats. Neuroscience 146, 1817-1828.
71. Milligan E.D. and Watkins L.R. (2009) Pathological and protective roles of glia in chronic pain. Nature Reviews Neuroscience 10, 23-36.
72. Nakajima K. and Kohsaka S. (2001) Microglia: activation and their sig-nificance in the central nervous system. Journal of Biochemistry (Tokyo) 130, 169-175.
73. Nasu-Tada K., Koizumi S., Tsuda M., Kunifusa E. and Inoue K. (2006) Possible involvement of increase in spinal fibronectin following per-ipheral nerve injury in upregulation ofmicroglial P2X4, a key molecule for mechanical allodynia. Glia 53, 769-775.
74. Nimmerjahn A., Kirchhoff F. and Helmchen F. (2005) Resting micro-glial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318.
75. North R.A. (2002) Molecular physiology of P2X receptors. Physiological Review 82, 1013-1067.
76. Obata K., Yamanaka H., Dai Y., Mizushima T., Fukuoka T., Tokunaga A. et al. (2004) Differential activation ofMAPK in injured and unin-jured DRG neurons following chronic constriction injury of the sciatic nerve in rats. European Journal of Neuroscience 20, 2881-2895.
77. Obata N., Mizobuchi S., Itano Y., Matsuoka Y., Kaku R., Tomotsuka N. et al. (2011) Decoy strategy targeting the brain-derived neurotrophic factor exon I to attenuate tactile allodynia in the neuropathic pain model of rats. Biochemical and Biophysical Research Communications 408, 139-144.
78. Perez-Medrano A., Donnelly-Roberts D.L., Honore P., Hsieh G.C., Namovic M.T., Peddi S. et al. (2009) Discovery and biological evalu-ation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain. Journal of Medicinal Chemistry 52, 3366-3376.
79. Portanova J.P., Zhang Y., Anderson G.D., Hauser S.D., Masferrer J.L., Seibert K. et al. (1996) Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. Journal of Experimental Medicine 184, 883-891.
80. Qureshi O.S., Paramasivam A., Yu J.C. and Murrell-Lagnado R.D. (2007) Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis. Journal ofCell Science 120, 3838-3849.
81. Rao J.S., Ertley R.N., Lee H.J., DeMar J.C. Jr., Arnold J.T., Rapoport S.I. et al. (2007) n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechan-ism. Molecular Psychiatry 12, 36-46.
82. Rivest S. (2009) Regulation of innate immune responses in the brain. Nature Reviews Immunology 9, 429-439.
83. Royle S.J., Bobanovic L.K. and Murrell-Lagnado R.D. (2002) Identification of a non-canonical tyrosine-based endocytic motif in an ionotropic receptor. Journal of Biological Chemistry 277, 35378-35385.
84. Samad T.A., Sapirstein A. and Woolf C.J. (2002) Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends in Molecular Medicine 8, 390-396.
85. Sasaki Y., Hoshi M., Akazawa C., Nakamura Y., Tsuzuki H., Inoue K. et al. (2003) Selective expression of Gi/o-coupled ATP receptor P2Y12 in microglia in rat brain. Glia 44, 242-250.
86. Scholz J. and Woolf C.J. (2002) Can we conquer pain? Nature Neuroscience 5 (Suppl.), 1062-1067.
87. Seil M., El O.M., Fontanils U., Etxebarria I.G., Pochet S., Dal M.G. et al. (2010) Ivermectin-dependent release of IL-1beta in response to ATP by peritoneal macrophages from P2X(7)-KO mice. Purinergic Signalling 6, 405-416.
88. Shinozaki Y., Sumitomo K., Tsuda M., Koizumi S., Inoue K. and Torimitsu K. (2009) Direct Observation of ATP-induced confor-mational changes in single P2X4 receptors. PLoS Biology 7, e103.
89. Skaper S.D., Debetto P. and Giusti P. (2010) The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB Journal 24, 337-345.
90. Sorge R.E., Trang T., Dorfman R., Smith S.B., Beggs S., Ritchie J. et al. (2012) Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Native Medicine 18, 595-599.
91. Sweitzer S.M., White K.A., Dutta C. and DeLeo J.A. (2002) The differ ential role of spinal MHC class II and cellular adhesion molecules in peripheral inflammatory versus neuropathic pain in rodents. Journal of Neuroimmunology 125, 82-93.
92. Tanga F.Y., Raghavendra V. and DeLeo J.A. (2004) Quantitative real-time RT-PCR assessment ofspinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochemistry International 45, 397-407.
93. Tao X., Finkbeiner S., Arnold D.B., Shaywitz A.J. and Greenberg M.E. (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20, 709-726.
94. Toulme E., Soto F., Garret M. and Boue-Grabot E. (2006) Functional properties of internalization-deficient P2X4 receptors reveal a novel mechanism of ligand-gated channel facilitation by ivermectin. Molecular Pharmacology 69, 576-587.
95. Toyomitsu E., Tsuda M., Yamashita T., Tozaki-Saitoh H., Tanaka Y. and Inoue K. (2012) CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia. Purinergic Signalling 2012 Jan 6 Epub ahead of print.
96. Tozaki-Saitoh H., Tsuda M., Miyata H., Ueda K., Kohsaka S. and Inoue K. (2008) P2Y12 receptors in spinal microglia are required for neuro-pathic pain after peripheral nerve injury. Journal of Neuroscience 28, 4949-4956.
97. Trang T., Beggs S. and Salter M.W. (2006) Purinoceptors in microglia and neuropathic pain. Pflugers Archives 452, 645-652.
98. Trang T., Beggs S. and Salter M.W. (2011) ATP receptors gate microglia signaling in neuropathic pain. Experimental Neurology 234, 354-361.
99. Trang T., Beggs S., Wan X. and Salter M.W. (2009) P2X4receptor mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. Journal of Neuroscience 29, 3518-3528.
100. Tsuda M., Inoue K. and Salter M.W. (2005) Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends in Neurosciences 28, 101-107.
101. Tsuda M., Mizokoshi A., Shigemoto-Mogami Y., Koizumi S. and Inoue K. (2004) Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45, 89-95.
102. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W. et al. (2003) P2X4 receptors induced in spinal micro-glia gate tactile allodynia after nerve injury. Nature 424, 778-783.
103. Tsuda M., Toyomitsu E., Komatsu T., Masuda T., Kunifusa E., Nasu-Tada K. et al. (2008a) Fibronectin/integrin system is involved in P2X(4) receptor upregulation in the spinal cord and neuropathic pain after nerve injury. Glia 56, 579-585.
104. Tsuda M., Tozaki-Saitoh H., Masuda T., Toyomitsu E., Tezuka T., Yamamoto T. et al. (2008b) Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury. Glia 56, 50-58.
105. Tsuda M., Kuboyama K., Inoue T., Nagata K., Tozaki-Saitoh H. and Inoue K. (2009a) Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays. Molecular Pain 5, 28.
106. Tsuda M., Masuda T., Kitano J., Shimoyama H., Tozaki-Saitoh H. and Inoue K. (2009b) IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proceedings of the National Academy ofSciences of the U.S.A. 106, 8032-8037.
107. Tsuda M., Toyomitsu E., Kometani M., Tozaki-Saitoh H. and Inoue K. (2009c) Mechanisms underlying fibronectin-induced up-regulation of P2X4R expression in microglia: distinct roles of PI3 K-Akt and MEK-ERK signalling pathways. Journal of Cellular and Molecular Medicine 13, 3251-3259.
108. Ulmann L., Hatcher J.P., Hughes J.P., Chaumont S., Green P.J., Conquet F. et al. (2008) Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. Journal of Neuroscience 28, 11263-11268.
109. Ulmann L., Hirbec H. and Rassendren F. (2010) P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflamma-tory pain. EMBO Journal 29, 2290-2300.
110. Voscopoulos C. and Lema M. (2010) When does acute pain become chronic? British Journal of Anaesthesia 105 (Suppl. 1), i69-i85.
111. Watkins L.R. and Maier S.F. (2003) Glia: a novel drugdiscovery target for clinical pain. Nature Reviews Drug Discovery 2, 973-985.
112. Watkins L.R., Milligan E.D. and Maier S.F. (2001) Glial activation: a driving force for pathological pain. Trends in Neurosciences 24, 450-455.
113. West A.E., Chen W.G., Dalva M.B., Dolmetsch R.E., Kornhauser J.M., Shaywitz A.J. et al. (2001) Calcium regulation of neuronal gene expression. Proceedings of the National Academy of Sciences of the U.S.A. 98, 11024-11031.
114. Woolf C.J. and Salter M.W. (2000) Neuronal plasticity: increasing the gain in pain. Science 288, 1765-1769.
115. Yuan H., Zhu X., Zhou S., Chen Q., Zhu X., Ma X. et al. (2010) Role of mast cell activation in inducing microglial cells to release neurotro-phin. Journal of Neuroscience Research 88, 1348-1354.
116. Zhang J. and De Koninck Y. (2006) Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. Journal of Neurochemistry 97, 772-783.
117. Zhao J., Seereeram A., Nassar M.A., Levato A., Pezet S., Hathaway G. et al. (2006) Nociceptor-derived brain-derived neurotrophic factor regulates acute and inflammatory but not neuropathic pain. Molecular and Cellular Neuroscience 31, 539-548.
118. Zhou Z., Hong E.J., Cohen S., Zhao W.N., Ho H.Y., Schmidt L. et al. (2006) Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnftranscription, dendritic growth, and spine maturation. Neuron 52, 255-269.
119. Zimmermann M. (2001) Pathobiology of neuropathic pain. European Journal ofPharmacology 429, 23-37.